rs34612342 — MUTYH Y179C

Most common pathogenic MUTYH variant; biallelic carriers develop MUTYH-Associated Polyposis with ~28-fold increased colorectal cancer risk, while heterozygous carriers have a modest CRC risk elevation (OR ~1.3)

See your personal result for MUTYH

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

MUTYH Y179C — The Most Common Base Excision Repair Defect

Every cell division exposes DNA to oxidative damage from normal metabolism. One of the most frequent and dangerous lesions is 8-oxoguanine11 8-oxoguanine
8-oxo-7,8-dihydroguanine (8-oxoG), a mutagenic oxidative DNA lesion that mispairs with adenine during replication, causing G:C to T:A transversion mutations if uncorrected (8-oxoG), which mispairs with adenine during replication. The MUTYH gene encodes a DNA glycosylase that patrols freshly replicated DNA, scanning for adenines that have been incorrectly inserted opposite 8-oxoG and excising them so the base excision repair22 base excision repair
A fundamental DNA repair pathway: a glycosylase removes the damaged or mismatched base, AP endonuclease nicks the backbone, polymerase fills the gap, and ligase seals it (BER) pathway can insert the correct cytosine. Y179C is the single most common pathogenic variant in MUTYH, accounting for approximately 50-55% of all disease-causing MUTYH alleles in Europeans. When both copies of the gene are non-functional — either homozygous Y179C or compound heterozygous with the other common variant G396D — the resulting condition is MUTYH-Associated Polyposis (MAP), with a dramatically elevated colorectal cancer risk.

The Mechanism

The Y179C variant substitutes tyrosine with cysteine at position 179 within the HhH-GPD domain33 HhH-GPD domain
The helix-hairpin-helix glycopeptidase D domain, a conserved structural motif in DNA glycosylases that directly contacts the DNA substrate and positions the catalytic residues for base excision of the MUTYH protein, a domain directly responsible for DNA binding and catalytic activity. This missense change severely disrupts the enzyme's ability to recognize adenine:8-oxoG mismatches and excise the misincorporated adenine. Functional studies demonstrate that Y179C MUTYH retains less than 2% of normal glycosylase activity — substantially less than the G396D variant, which retains roughly 2-5%. This explains why Y179C homozygotes develop disease earlier and with greater severity than G396D homozygotes.

Without functional MUTYH, adenine:8-oxoG mismatches persist through successive rounds of replication, converting them into permanent G:C to T:A transversion mutations. These transversions accumulate preferentially in the APC tumor suppressor gene44 APC tumor suppressor gene
Adenomatous Polyposis Coli, a gatekeeper tumor suppressor whose inactivation initiates the adenoma-carcinoma sequence in colorectal epithelium, inactivating it and initiating the formation of adenomatous polyps — the precursors to colorectal cancer.

MAP follows autosomal recessive inheritance55 autosomal recessive inheritance
Both copies of the gene must carry pathogenic variants for the full disease phenotype; carriers of a single mutant copy retain sufficient enzyme activity from the normal allele. Biallelic carriers (homozygous Y179C or compound heterozygous Y179C/G396D) develop tens to hundreds of colorectal adenomas, typically presenting between ages 40 and 55. Heterozygous carriers retain one fully functional MUTYH allele and have near-normal BER capacity.

The Evidence

The landmark 2002 study66 landmark 2002 study
Al-Tassan N et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet, 2002 by Al-Tassan and colleagues first identified biallelic MUTYH mutations — including the Y179C variant — in a family with multiple colorectal adenomas carrying a characteristic excess of somatic G:C to T:A transversions in the APC gene. This landmark discovery established a new mechanism for hereditary colorectal cancer: defective base excision repair.

Sieber et al.77 Sieber et al.
Sieber OM et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med, 2003 confirmed the association by screening 152 patients with multiple adenomas and 107 with classic familial adenomatous polyposis, demonstrating that biallelic MYH mutations predispose to a recessive polyposis phenotype.

The largest risk quantification comes from a meta-analysis of 20,565 cases and 15,524 controls88 meta-analysis of 20,565 cases and 15,524 controls
Theodoratou E et al. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer, 2010. Biallelic MUTYH carriers had an odds ratio of 28 (95% CI 6.95-115) for colorectal cancer. For monoallelic Y179C carriers specifically, the OR was 1.34 (95% CI 1.01-1.77) — a modest, borderline-significant elevation. Overall monoallelic MUTYH carrier OR was 1.16 (95% CI 1.00-1.34).

Nielsen et al.99 Nielsen et al.
Nielsen M et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology, 2009 studied 257 MAP patients and found critical genotype-phenotype differences: Y179C homozygotes presented with CRC at a mean age of 46, compound heterozygotes (Y179C/G396D) at 52, and G396D homozygotes at 58. This confirms that Y179C is the more severe of the two common variants, consistent with its greater loss of glycosylase activity.

Practical Implications

For GG individuals: both copies of MUTYH function normally. Your base excision repair pathway handles oxidative DNA damage effectively at this locus.

For AG (heterozygous carrier) individuals: you carry one non-functional copy of MUTYH. Your remaining functional allele provides adequate DNA repair. The primary considerations are a modest personal CRC risk elevation (OR ~1.3) and the reproductive implications — if your partner also carries a pathogenic MUTYH variant, each child has a 25% chance of developing MAP. Beginning colonoscopy screening at age 40 is appropriate given the carrier status.

For AA (biallelic) individuals: you have MUTYH-Associated Polyposis. ACG guidelines1010 ACG guidelines
Syngal S et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol, 2015 recommend colonoscopy every 1-2 years starting at age 25-30. Annual colonoscopy with polypectomy if adenomas are found. Upper endoscopy for duodenal adenomas should begin at age 30-35. Colectomy may become necessary if polyp burden exceeds what can be managed endoscopically.

Interactions

The most clinically important interaction is with G396D (rs36053993)1111 G396D (rs36053993)
The second most common MUTYH pathogenic variant, accounting for 25-30% of disease alleles in Europeans; it affects the nudix hydrolase domain rather than the HhH-GPD domain, the other common MUTYH pathogenic variant. Compound heterozygosity — carrying one Y179C allele and one G396D allele — produces the full MAP phenotype, functionally equivalent to homozygosity for either variant. This compound heterozygous state is common among MAP patients because the two variants segregate independently and together account for 75-85% of pathogenic MUTYH alleles in Europeans.

If a user is heterozygous at both rs34612342 (Y179C carrier, AG) and rs36053993 (G396D carrier, AG), they are compound heterozygous and should follow the full MAP surveillance protocol — colonoscopy every 1-2 years from age 25-30, upper endoscopy from age 30-35. This compound action is critical because neither individual carrier genotype alone triggers the intensive surveillance recommendation. The compound Y179C/G396D genotype carried a mean CRC diagnosis age of 52 in the Nielsen et al. study, intermediate between Y179C homozygotes (age 46) and G396D homozygotes (age 58).

Genotype Interpretations

What each possible genotype means for this variant.

TT Normal DNA Repair Normal

Normal MUTYH function — intact base excision repair at this locus

With two functional copies of MUTYH, your base excision repair pathway operates at full capacity for correcting 8-oxoguanine-related mismatches. The MUTYH glycosylase scans newly replicated DNA for adenines incorrectly paired with 8-oxoG and excises them, allowing the correct cytosine to be inserted. This prevents the accumulation of G:C to T:A transversion mutations that drive colorectal carcinogenesis.

This genotype does not eliminate all colorectal cancer risk — CRC is a complex disease with many genetic and environmental contributors. But you do not carry the MUTYH Y179C variant, and your oxidative DNA repair at this locus is normal.

CT Carrier Carrier

One copy of Y179C — MUTYH carrier with near-normal DNA repair

Heterozygous carriers of pathogenic MUTYH variants retain one fully functional allele, which provides adequate glycosylase activity for base excision repair. The large meta-analysis by Theodoratou et al. found a monoallelic Y179C odds ratio of 1.34 (95% CI 1.01-1.77) for colorectal cancer. A separate study of obligate carriers (parents of MAP patients) by Jones et al. found a standardized incidence ratio of 2.12 (95% CI 1.30-3.28), though this may overestimate risk due to ascertainment bias.

The primary concern with carrier status is reproductive. If your partner also carries a pathogenic MUTYH variant (either Y179C or G396D), each child has a 25% chance of inheriting two non-functional copies and developing MUTYH-Associated Polyposis. Given that MUTYH carrier frequency is approximately 1-2% in European populations, the chance of a random partner also being a carrier is low but not negligible.

Y179C is the more common of the two major MUTYH pathogenic variants, accounting for approximately 50-55% of all disease-causing MUTYH alleles in Europeans. The other major variant is G396D (rs36053993), which accounts for 25-30%.

CC Biallelic MUTYH Homozygous

Two copies of Y179C — MUTYH-Associated Polyposis requiring aggressive surveillance from age 25

Biallelic Y179C eliminates functional MUTYH glycosylase activity. The Y179C protein retains less than 2% of normal enzyme activity, less than any other common MUTYH variant. Without this critical DNA repair enzyme, adenine:8-oxoguanine mismatches persist through successive rounds of replication, permanently converting them into G:C to T:A transversion mutations. These transversions accumulate preferentially in the APC tumor suppressor gene, initiating the adenoma-carcinoma sequence.

The meta-analysis by Theodoratou et al. (20,565 cases, 15,524 controls) found an odds ratio of 28 (95% CI 6.95-115) for colorectal cancer in biallelic MUTYH carriers. The Nielsen et al. study of 257 MAP patients demonstrated that Y179C homozygotes present with CRC at a mean age of 46, significantly earlier than compound Y179C/G396D heterozygotes (age 52) and G396D homozygotes (age 58). This makes Y179C homozygosity the most severe common MUTYH genotype.

MAP typically produces 10 to several hundred colorectal adenomas (attenuated polyposis phenotype). Beyond colorectal cancer, biallelic MUTYH carriers have elevated risks for duodenal adenomas, ovarian cancer, bladder cancer, and skin tumors. The critical window for initiating surveillance is age 25 — earlier than for G396D homozygotes due to the younger age of cancer onset.

ACG and NCCN guidelines recommend colonoscopy every 1-2 years from age 25-30. If polyp burden becomes unmanageable endoscopically (typically more than 20 adenomas or high-grade dysplasia), prophylactic subtotal colectomy should be discussed.